Пошук по сайту

Авторизація

Періодика

Партнери

Поиск информации по диагнозу / Med And Me

Технічна підтримка

Європейський ринок пристроїв темічної абляції (European Thermal Ablation Devices Market)

In the medical devices industry, the term “ablation”—primarily referring to radiofrequency or RF ablation—has become a common description attached to devices that “kill or remodel selective tissue without vaporizing the major structures themselves.” Today, minimally invasive thermal ablation involves not only RF, but laser, microwave and high-intensity focused ultrasound (HIFU) technologies that are commonly utilized in several established, growing, technology-driven medical treatment areas such as benign prostatic hyperplasia (BPH), cancer/tumor ablation, endometrial ablation/menorrhagia, and the treatment of chronic venous insufficiency/varicose veins.

Combined, the European thermal ablation devices market—including sales derived from generators and energy-based catheters, electrodes/probes, disposables, procedure kits, and accessories used in the treatment of BPH, cancer/tumors, menorrhagia, and chronic venous insufficiency/varicose veins in the countries of France, Germany, Italy, Spain, and the United Kingdom—totaled more than an estimated $250 million. Despite ongoing European economic instability and severe budget constraints, each market segment profiled in this report is expected to increase at conservative yet positive compound annual growth rates over the next five years—ranging from approximately 2.6%-3.3%—due to growing demand, cost-efficiency and efficacy, the gradual adoption of improved, next-generation technologies, and an aging European population susceptible to various diseases/conditions.

This dynamic report from Medtech Insight includes analyses of leading products, markets, competitors, and emerging medical device technologies and opportunities. Covered products in this report include selected specialized energy-based generator systems, medical devices/instruments/accessories for the following minimally invasive or nonsurgical ablation treatment areas: BPH, cancer, chronic venous insufficiency/varicose veins, menorrhagia, as well as selected aesthetic areas, including skin rejuvenation/skin tightening and body sculpting/cellulite/targeted fat reduction. Other applications discussed include treatment of spinal denervation, stress urinary incontinence, and uterine fibroids.

TABLE OF CONTENTS

EXECUTIVE SUMMARY

i. Overview of Thermal Ablation

ii. European Market for Thermal Ablation Devices

iii. Methodology

Exhibit ES-1: Thermal Effects on Tissue

Exhibit ES-2: European Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016

Exhibit ES-3: European Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016

1. SELECTED EUROPEAN HEALTHCARE MARKETS

1.1 The European Union

1.1.1 A Common Currency

1.1.1.1 The Sovereign Debt Crisis

1.1.2 Late Payments Directive
1.1.3 Regulatory Policies
1.1.4 Reimbursement
1.1.5 Healthcare Spending

1.2 Selected European National Healthcare Profiles

1.2.1 France

1.2.1.1 Healthcare Organization and Reform
1.2.1.2 Hospital Services
1.2.1.3 Medical Services/Supplies Reimbursement

1.2.2 Germany

1.2.2.1 Healthcare Organization and Reform
1.2.2.2 Hospital Services
1.2.2.3 Medical Services/Supplies Reimbursement

1.2.3 Italy

1.2.3.1 Healthcare Organization and Reform
1.2.3.2 Hospital Services
1.2.3.3 Medical Services/Supplies Reimbursement

1.2.4 Spain

1.2.4.1 Healthcare Organization and Reform
1.2.4.2 Hospital Services
1.2.4.3 Medical Services/Supplies Reimbursement

1.2.5 United Kingdom

1.2.5.1 Healthcare Organization and Reform
1.2.5.2 Hospital Services
1.2.5.3 Medical Services/Supplies Reimbursement

Exhibit 1-1: European Union, Medical Device Risk Classification System
Exhibit 1-2: European Union Population Statistics Comparison for the Years 2000, 2010, and 2020
Exhibit 1-3: France, Selected National Healthcare Statistics
Exhibit 1-4: Germany, Selected National Healthcare Statistics
Exhibit 1-5: Italy, Selected National Healthcare Statistics
Exhibit 1-6: Spain, Selected National Healthcare Statistics
Exhibit 1-7: United Kingdom, Selected National Healthcare Statistics

2. THERMAL ABLATION DEVICES OVERVIEW

2.1 Applications for Thermal Ablation

2.1.1 Aesthetics—Skin Rejuvenation and Tightening

2.1.1.1 Alma Lasers
2.1.1.2 Cutera
2.1.1.3 Cynosure
2.1.1.4 Palomar Medical Technologies
2.1.1.5 Solta Medical
2.1.1.6 Syneron Medical

2.1.2 Aesthetics—Body Sculpting, Fat Reduction, and the Reduction in the Appearance of Cellulite

2.1.2.1 Cutera
2.1.2.2 Cynosure
2.1.2.3 Osyris Medical/LSO Medical
2.1.2.4 Solta Medical
2.1.2.5 Syneron Medical
2.1.2.6 Zeltiq Aesthetics

2.1.3 Benign Prostatic Hyperplasia

2.1.3.1 Transurethral Microwave Thermotherapy

2.1.3.1.1 American Medical Systems/Endo Health Solutions
2.1.3.1.2 Boston Scientific
2.1.3.1.3 ProstaLund Operations
2.1.3.1.4 Urologix

2.1.3.2 Transurethral Needle Ablation
2.1.3.3 Laser- and Other Energy-Based Therapies

2.1.3.3.1 Holmium Laser Ablation/Enucleation of the Prostate

2.1.3.3.1.1 Lumenis

2.1.3.3.2 Photoselective Vaporization of the Prostate

2.1.3.3.2.1 American Medical Systems/Endo Health Solutions

2.1.4 Cancer/Tumor Ablation

2.1.4.1 Radiofrequency Ablation

2.1.4.1.1 AngioDynamics
2.1.4.1.2 Boston Scientific
2.1.4.1.3 Celsion
2.1.4.1.4 Covidien
2.1.4.1.5 Thermedical

2.1.4.2 Other Ablation Methods

2.1.4.2.1 Cryoablation

2.1.4.2.1.1 Sanarus Technologies

2.1.4.2.2 Microwave Ablation

2.1.4.2.2.1 Covidien
2.1.4.2.2.2 Microsulis Medical and AngioDynamics

2.1.4.2.3 High-Intensity Focused Ultrasound

2.1.4.2.3.1 EDAP TMS
2.1.4.2.3.2 InSightec/ Elbit Imaging

2.1.5 Menorrhagia/Endometrial Ablation

2.1.5.1 Boston Scientific
2.1.5.2 CooperSurgical/The Cooper Companies
2.1.5.3 Ethicon/Johnson & Johnson
2.1.5.4 Hologic

2.1.6 Spinal Decompression and Denervation

2.1.6.1 ArthroCare
2.1.6.2 Relievant Medsystems
2.1.6.3 Smith & Nephew

2.1.7 Stress Urinary Incontinence

2.1.7.1 Novasys Medical

2.1.8 Varicose Vein Ablation

2.1.8.1 AngioDynamics
2.1.8.2 CermaVEIN
2.1.8.3 Covidien

2.1.9 Uterine Fibroids

2.1.9.1 InSightec/Elbit Imaging
2.1.9.2 Philips Healthcare/Royal Philips Electronics

Exhibit 2-1: Thermal Effects on Tissue
Exhibit 2-2: The Accent Radiofrequency Platform
Exhibit 2-3: The Pixel CO2 Fractional Laser System and Technology
Exhibit 2-4: The Thermage CPT System
Exhibit 2-5: Sublative and Sublime Skin Rejuvenation Technologies
Exhibit 2-6: The TruSculpt Body Sculpting System
Exhibit 2-7: The Cellulaze Cellulite Laser Workstation
Exhibit 2-8: The Smartlipo LaserBodySculpting Workstations
Exhibit 2-9: The LipoControl GPS Laser Assisted Lipolysis System
Exhibit 2-10: A Step-by-Step LipoSonix Procedure
Exhibit 2-11: The VelaShape II System
Exhibit 2-12: The UltraShape Contour I Body Sculpting System
Exhibit 2-13: The CoolSculpting System and Step-by-Step Process
Exhibit 2-14: Advantages and Disadvantages of Minimally Invasive Therapy for Benign Prostatic Hyperplasia
Exhibit 2-15: The CoreTherm System
Exhibit 2-16: Five-Year Clinical Comparison of Symptomatic Reduction in Benign Prostatic Hyperplasia Using the CoreTherm System and Competitive Treatments
Exhibit 2-17: The CoolWave and Targis Systems
Exhibit 2-18: The Cooled ThermCath Advance Catheter
Exhibit 2-19: Cooled ThermoTherapy, Selected Five-Year Clinical Trial Results
Exhibit 2-20: Comparison of Cooled ThermoTherapy with Drug Therapy, Selected Clinical Results
Exhibit 2-21: The Prostiva Radiofrequency Therapy System
Exhibit 2-22: Holmium Laser Ablation of the Prostate Using the VersaPulse PowerSuite Laser System
Exhibit 2-23: Selected Advantages of Holmium Laser Ablation Using the VersaPulse PowerSuite Compared with Photoselective Vaporization Using the GreenLight PV
Exhibit 2-24: The GreenLight High Performance System
Exhibit 2-25: The GreenLight Xcelerated Performance System
Exhibit 2-26: The MoXy Liquid Cooled Fiber
Exhibit 2-27: The Model 1500X Electrosurgical Generator, and StarBurst Xli-Enhanced and Semi-Flex Electrodes
Exhibit 2-28: The StarBurst SDE and MRI Electrodes
Exhibit 2-29: The NanoKnife Low Energy Direct Current System and Electrode Probes
Exhibit 2-30: The RF 3000 Generator and LeVeen Needle Electrode
Exhibit 2-31: The Cool-tip RF Ablation System
Exhibit 2-32: The Cool-tip RF Ablation System E Series
Exhibit 2-33: The HALOFLEX System
Exhibit 2-34: The SERF Ablation System
Exhibit 2-35: The Visica 2 Treatment System and Step-by-Step Cryoablation Process
Exhibit 2-36: The Evident MWA System
Exhibit 2-37: The Acculis MTA System and Three-Step Procedure
Exhibit 2-38: The Ablatherm Robotic HIFU System
Exhibit 2-39: The ExAblate System
Exhibit 2-40: Breast Cancer Treatment Using the ExAblate System
Exhibit 2-41: The Three-Step Endometrial Ablation Process Using the Genesys Hydro ThermAblator System
Exhibit 2-42: The Her Option Cryoablation System
Exhibit 2-43: The Gynecare ThermaChoice III Uterine Balloon Therapy System and a Comparison of Selected Outcome Data with Competitive Thermal Ablation Systems
Exhibit 2-44: The NovaSure System and Step-by-Step Endometrial Ablation Process
Exhibit 2-45: Selected Features of the Next-Generation NovaSure System
Exhibit 2-46: Nucleoplasty Using Coblation Technology
Exhibit 2-47: Intradiscal Electrothermal Therapy and Targeted Disc Decompression
Exhibit 2-48: Renessa Treatment for Stress Urinary Incontinence
Exhibit 2-49: The VenaCure EVLT System
Exhibit 2-50: The SVS System for the Treatment of Varicose Veins
Exhibit 2-51: The Venefit Targeted Endovenous Therapy System
Exhibit 2-52: Endovenous Ablation Using the Venefit System
Exhibit 2-53: Uterine Fibroid Treatment Using the ExAblate System
Exhibit 2-54: Sonalleve Therapy

3. EUROPEAN THERMAL ABLATION DEVICES MARKET

3.1 Procedure Volumes
3.2 Market Forecast
3.3 Competitive Analysis

3.3.1 Benign Prostatic Hyperplasia Ablation
3.3.2 Cancer/Tumor Ablation
3.3.3 Endometrial Ablation
3.3.4 Endovenous Ablation

3.4 Other Thermal Ablation Markets

3.4.1 Aesthetics

3.4.1.1 Body Sculpting/Fat Reduction

3.4.2 Spinal Disc Decompression and Denervation

Exhibit 3-1: Europe, Thermal Ablation, Procedure Volumes Forecast, by Type, 2011-2016
Exhibit 3-2: European Thermal Ablation Devices for Medically Necessary Care, Combined Market Forecast, 2011-2016
Exhibit 3-3: European Thermal Ablation Devices for Medically Necessary Care, Market Forecast, by Treatment Segment, 2011-2016
Exhibit 3-4: 2011, European Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment
Exhibit 3-5: 2016, European Thermal Ablation Devices Market for Medically Necessary Care, Share of Sales, by Segment
Exhibit 3-6: 2011, Benign Prostatic Hyperplasia Laser Ablation Products Market, Share by Supplier
Exhibit 3-7: 2011, Benign Prostatic Hyperplasia Microwave and Radiofrequency Ablation Products Market, Share by Supplier
Exhibit 3-8: 2011, Tumor Ablation Products Market, Share by Supplier
Exhibit 3-9: 2011, Endometrial Ablation Products Market, Share by Supplier
Exhibit 3-10: 2011, Endovenous Ablation Products Market, Share by Supplier
Exhibit 3-11: Leading Nonsurgical Aesthetic Device Companies,Global Revenues, 2010-2011
Exhibit 3-12: 2011, Global Nonsurgical Aesthetic Devices Market, Share by Supplier
Exhibit 3-13: 2012, Selected Nonsurgical Body Sculpting/Fat Reduction Systems

4. COMPANY PROFILES

4.1 AngioDynamics, Inc.
4.2 Boston Scientific Corporation
4.3 Covidien PLC
4.4 Endo Health Solutions, Inc.
4.5 Hologic, Inc.
4.6 InSightec LTD/Elbit Imaging LTD
4.7 Johnson & Johnson
4.8 Microsulis Medical LTD
4.9 Solta Medical, Inc.
4.10 Syneron Medical LTD
4.11 Zeltiq Aesthetics, Inc.

Publisher: Medtech Insight
Перекладач: translate.google.com

Європейський ринок пристроїв темічної абляції (European Thermal Ablation Devices Market)
Європейський ринок електрохірургічних пристроїв (European Electrosurgical Devices Market)
Американський ринок приладів термічної абляції (U.S. Thermal Ablation Devices Market)
Американський ринок електрохірургічних пристроїв (U.S. Electrosurgical Devices Market)

Новини

21.10.2019  Інженери придумали, як проводити моніторинг стану тіла в режимі реального часу
21.10.2019  Дослідження показало: паперові та аудіокниги для мозку ідентичні
21.10.2019  Хіміки підійшли ближче до позбавлення від туберкульозу
20.10.2019  Омега-3 однозначно допомагає знизити рівень холестерину
20.10.2019  На Рівненщині замовили перевірку на забруднення повітря після вибуху на підприємстві
19.10.2019  Відновити здоров'я кишечника допоможуть волоські горіхи
19.10.2019  Лікарі: при високому кров'яному тиску краще не їсти звичайний сир
18.10.2019  Дослідники представили новий метод лікування важких недуг
18.10.2019  Вчені дізналися, як послабити залежність від знеболювальних
18.10.2019  Генетична мутація стоїть за поширеним порушенням мови
18.10.2019  Серед копалин дослідники виявили агент, що діє проти небезпечного вірусу
18.10.2019  Серцевий напад можна діагностувати по одній краплі крові
17.10.2019  Людям почнуть пересаджувати органи свиней, прогнозують експерти
17.10.2019  Дослідники виявили несподівані ліки від облисіння
17.10.2019  Проблеми зі сном і стан серця пов'язані, показало дослідження
17.10.2019  В Україні удвічі знизився рівень захворюваності на сказ
17.10.2019  Медики дали поради, як перейти на здорове харчування
16.10.2019  Дослідники намацали новий напрямок в лікуванні болю
16.10.2019  Експериментальна вакцина зупинить поширення хламідіозу
16.10.2019  Україна та ще чотири держави проведуть паралельний аудит щодо туберкульозу